|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 22 of 50 found articles
| Title: |
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study |
| Author: |
Hellmann, Matthew D Rizvi, Naiyer A Goldman, Jonathan W Gettinger, Scott N Borghaei, Hossein Brahmer, Julie R Ready, Neal E Gerber, David E Chow, Laura Q Juergens, Rosalyn A Shepherd, Frances A Laurie, Scott A Geese, William J Agrawal, Shruti Young, Tina C Li, Xuemei Antonia, Scott J |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 18 (2017) nr. 1 pages 31-41 |
| Year: |
2017 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 22 of 50 found articles
| << previous | next >> |